Myron Holubiak

2018

In 2018, Myron Holubiak earned a total compensation of $681.3K as Chief Executive Officer at Citius Pharmaceuticals, a 2% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$186,750
Option Awards$44,572
Salary$450,000
Total$681,322

Holubiak received $450K in salary, accounting for 66% of the total pay in 2018.

Holubiak also received $186.8K in non-equity incentive plan and $44.6K in option awards.

Rankings

In 2018, Myron Holubiak's compensation ranked 10,823rd out of 14,244 executives tracked by ExecPay. In other words, Holubiak earned more than 24.0% of executives.

ClassificationRankingPercentile
All
10,823
out of 14,244
24th
Division
Manufacturing
4,365
out of 5,765
24th
Major group
Chemicals And Allied Products
1,647
out of 2,128
23rd
Industry group
Drugs
1,396
out of 1,817
23rd
Industry
Pharmaceutical Preparations
1,072
out of 1,391
23rd
Source: SEC filing on December 20, 2018.

Holubiak's colleagues

We found two more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2018.

2018

Jaime Bartushak

Citius Pharmaceuticals

Chief Financial Officer

2018

Leonard Mazur

Citius Pharmaceuticals

Chairman

News

You may also like